Voloridge Investment Management
VIR icon

Voloridge Investment Management’s Vir Biotechnology VIR Stock Holding History

Voloridge Investment Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-327,393
Closed -$1.97M – 1310
2025
Q4 		$1.97M Sell
327,393
-189,235
-37% -$1.13M 0.01% 917
2025
Q3 		$2.95M Sell
516,628
-272,878
-35% -$1.4M 0.01% 859
2025
Q2 		$3.98M Sell
789,506
-270,649
-26% -$1.45M 0.01% 810
2025
Q1 		$6.87M Buy
1,060,155
+290,430
+38% +$2.58M 0.03% 691
2024
Q4 		$5.65M Sell
769,725
-205,575
-21% -$1.62M 0.02% 745
2024
Q3 		$7.3M Sell
975,300
-249,598
-20% -$2.17M 0.03% 680
2024
Q2 		$10.9M Buy
1,224,898
+521,370
+74% +$5M 0.04% 543
2024
Q1 		$7.13M Buy
703,528
+149,722
+27% +$1.52M 0.03% 566
2023
Q4 		$5.57M Buy
553,806
+113,038
+26% +$1.03M 0.02% 593
2023
Q3 		$4.13M Buy
+440,768
New +$6.29M 0.02% 716
2022
Q1 		– Sell
-355,091
Closed -$14.9M – 1721
2021
Q4 		$14.9M Buy
355,091
+153,578
+76% +$6.02M 0.08% 350
2021
Q3 		$8.77M Sell
201,513
-6,656
-3% -$288K 0.06% 475
2021
Q2 		$9.84M Sell
208,169
-75,600
-27% -$3.44M 0.07% 416
2021
Q1 		$14.5M Sell
283,769
-67,356
-19% -$3.63M 0.11% 259
2020
Q4 		$9.4M Buy
+351,125
New +$11.4M 0.08% 283

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Voloridge Investment Management's VIR Position: Q1 2026 in Review

Voloridge Investment Management sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 327,393 shares — an estimated $1.97M sold.

Voloridge Investment Management first reported a position in VIR in Q4 2020 and held it in 15 quarters. The position peaked at $14.9M in Q4 2021. 252 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Voloridge Investment Management reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 327,393 Vir Biotechnology shares in Q1 2026, an estimated $1.97M.
  • Voloridge Investment Management first reported a position in Vir Biotechnology in Q4 2020 and held it in 15 quarters.
  • Voloridge Investment Management's Vir Biotechnology position peaked at $14.9M in Q4 2021.
  • 252 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.